BACKGROUND: Peanut allergy is the leading cause of food-related anaphylaxis, and accidental exposures are common. Oral immunotherapy (OIT) has been posited as a potential treatment. METHODS: Patients aged 3-65 years with peanut-specific IgE ≥7 kU/l and/or a positive skin prick test with a history of an allergic reaction to peanut were recruited to undergo an OIT protocol. All adverse reactions were recorded by research staff or patients in real time. RESULTS: Twenty-four patients received 6,662 doses. Symptoms were mostly mild (84%), and only 3 severe gastrointestinal reactions required the administration of epinephrine. Abdominal pain was the most common reaction, followed by oropharyngeal and lip pruritus. Respiratory symptoms were rare. CONCLUSIONS: In this trial of OIT in adults and children, most reactions were mild.
BACKGROUND: Peanut allergy is the leading cause of food-related anaphylaxis, and accidental exposures are common. Oral immunotherapy (OIT) has been posited as a potential treatment. METHODS: Patients aged 3-65 years with peanut-specific IgE ≥7 kU/l and/or a positive skin prick test with a history of an allergic reaction to peanut were recruited to undergo an OIT protocol. All adverse reactions were recorded by research staff or patients in real time. RESULTS: Twenty-four patients received 6,662 doses. Symptoms were mostly mild (84%), and only 3 severe gastrointestinal reactions required the administration of epinephrine. Abdominal pain was the most common reaction, followed by oropharyngeal and lip pruritus. Respiratory symptoms were rare. CONCLUSIONS: In this trial of OIT in adults and children, most reactions were mild.
Authors: Richard L Wasserman; Robert W Sugerman; Nana Mireku-Akomeah; Lyndon Mansfield; James W Baker Journal: J Allergy Clin Immunol Date: 2010-10-30 Impact factor: 10.793
Authors: Ananth Thyagarajan; Pooja Varshney; Stacie M Jones; Scott Sicherer; Robert Wood; Brian P Vickery; Hugh Sampson; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2010-07 Impact factor: 10.793
Authors: S A Bock; H A Sampson; F M Atkins; R S Zeiger; S Lehrer; M Sachs; R K Bush; D D Metcalfe Journal: J Allergy Clin Immunol Date: 1988-12 Impact factor: 10.793
Authors: Stacie M Jones; Laurent Pons; Joseph L Roberts; Amy M Scurlock; Tamara T Perry; Mike Kulis; Wayne G Shreffler; Pamela Steele; Karen A Henry; Margaret Adair; James M Francis; Stephen Durham; Brian P Vickery; Xiaoping Zhong; A Wesley Burks Journal: J Allergy Clin Immunol Date: 2009-07-03 Impact factor: 10.793
Authors: Yamini V Virkud; A Wesley Burks; Pamela H Steele; Lloyd J Edwards; Jelena P Berglund; Stacie M Jones; Amy M Scurlock; Tamara T Perry; Robert D Pesek; Brian P Vickery Journal: J Allergy Clin Immunol Date: 2016-09-05 Impact factor: 10.793
Authors: Weiqi Wang; Shu-Chen Lyu; Xuhuai Ji; Sheena Gupta; Monali Manohar; Gopal K R Dhondalay; Sharon Chinthrajah; Sandra Andorf; Scott D Boyd; Robert Tibshirani; Stephen J Galli; Kari C Nadeau; Holden T Maecker Journal: Clin Immunol Date: 2020-08-09 Impact factor: 3.969
Authors: Philippe Bégin; Lisa C Winterroth; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Elisabeth Hoyte; Gerri O'Riordan; Scott Seki; Alanna Blakemore; Margie Woch; Robert G Hamilton; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-01-15 Impact factor: 3.406
Authors: Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau Journal: Allergy Asthma Clin Immunol Date: 2014-02-20 Impact factor: 3.406